USE OF MVA TO TREAT PROSTATE CANCER

• 收藏
• 分享

专利权人:

BN IMMUNOTHERAPEUTICS INC.

发明人:

DELCAYRE, ALAIN,LAUS, REINER,MANDL, STEFANIE,ROUNTREE, RYAN, BLAIR,LEGRAND, FATEMA

申请号：

NZ58404208

公开号：

NZ584042A

申请日:

2008.10.16

申请国别(地区):

NZ

年份:

2012

代理人:

摘要：

Disclosed are compositions, kits, and methods for cancer prophylaxis and therapy using recombinant MVA viruses encoding tumor-associated antigens, such as PSA and PAP. The recombinant MVA viruses can induce B- and T-cell responses. The recombinant MVA viruses can be administered prior to, at the same time as, or after a taxane.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/